NCT06164977Completed
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
Source: ClinicalTrials.gov · Last updated 11 Jun 2025
Brief summary (registry, in English)
Aim of the study is to evaluate chronic total coronary occlusion treatment results 6 years after bioresorbable scaffold implantation by quantitative coronary analysis, intravascular ultrasound and optical coherence tomography.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 22 Nov 2023
- Start date
- 1 Feb 2017
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Pauls Stradins Clinical University Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT06164977
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 1 Feb 2017 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participant withdrawal from study.
Who the study is looking for
- 100% occlusion of a coronary artery for a duration of greater than or equal to 3 months based on angiographic evidence.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pauls Stradins Clinical University Hospital Coordinator of this site? Confirm its status | Riga | Latvia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.